Autobio Diagnostics Co., Ltd. (603658.SS)
CNY 44.66
(-3.17%)
CNY 44.66
(-3.17%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 2.83 Billion CNY | 1.91% |
| 2022 | 2.65 Billion CNY | 18.64% |
| 2021 | 2.24 Billion CNY | 25.9% |
| 2020 | 1.77 Billion CNY | -0.24% |
| 2019 | 1.78 Billion CNY | 39.26% |
| 2018 | 1.28 Billion CNY | 35.55% |
| 2017 | 944.9 Million CNY | 33.91% |
| 2016 | 705.6 Million CNY | 35.34% |
| 2015 | 521.37 Million CNY | 26.67% |
| 2014 | 411.59 Million CNY | 42.44% |
| 2013 | 288.95 Million CNY | 27.68% |
| 2012 | 226.31 Million CNY | 48.94% |
| 2011 | 151.94 Million CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q3 | 783.49 Million CNY | 12.3% |
| 2024 Q1 | 691.84 Million CNY | -7.66% |
| 2024 Q2 | 697.67 Million CNY | 0.84% |
| 2023 Q3 | 752.8 Million CNY | 6.21% |
| 2023 Q4 | 749.2 Million CNY | -0.48% |
| 2023 Q1 | 632.82 Million CNY | -8.6% |
| 2023 FY | 2.7 Billion CNY | 1.91% |
| 2023 Q2 | 708.78 Million CNY | 12.0% |
| 2022 Q4 | 692.35 Million CNY | -7.47% |
| 2022 Q3 | 748.23 Million CNY | 21.33% |
| 2022 Q1 | 600.7 Million CNY | -4.76% |
| 2022 FY | 2.65 Billion CNY | 18.64% |
| 2022 Q2 | 616.68 Million CNY | 2.66% |
| 2021 Q3 | 604.88 Million CNY | 13.01% |
| 2021 FY | 2.24 Billion CNY | 25.9% |
| 2021 Q1 | 469.45 Million CNY | -14.18% |
| 2021 Q2 | 535.22 Million CNY | 14.01% |
| 2021 Q4 | 630.71 Million CNY | 4.27% |
| 2020 Q3 | 523.61 Million CNY | 34.23% |
| 2020 FY | 1.77 Billion CNY | -0.24% |
| 2020 Q1 | 318.7 Million CNY | -38.92% |
| 2020 Q2 | 390.08 Million CNY | 22.4% |
| 2020 Q4 | 547 Million CNY | 4.47% |
| 2019 Q3 | 491.21 Million CNY | 18.61% |
| 2019 Q2 | 414.15 Million CNY | 16.17% |
| 2019 FY | 1.78 Billion CNY | 39.26% |
| 2019 Q4 | 521.8 Million CNY | 6.23% |
| 2019 Q1 | 356.51 Million CNY | -4.31% |
| 2018 Q3 | 342.28 Million CNY | 15.14% |
| 2018 Q4 | 372.58 Million CNY | 8.85% |
| 2018 FY | 1.28 Billion CNY | 35.55% |
| 2018 Q1 | 268.7 Million CNY | -4.07% |
| 2018 Q2 | 297.28 Million CNY | 10.64% |
| 2017 Q3 | 259.45 Million CNY | 10.28% |
| 2017 FY | 944.9 Million CNY | 33.91% |
| 2017 Q4 | 280.09 Million CNY | 7.96% |
| 2017 Q1 | 170.07 Million CNY | -16.61% |
| 2017 Q2 | 235.27 Million CNY | 38.33% |
| 2016 Q1 | 138.24 Million CNY | -4.87% |
| 2016 Q3 | 189.81 Million CNY | 9.34% |
| 2016 Q4 | 203.94 Million CNY | 7.45% |
| 2016 Q2 | 173.6 Million CNY | 25.58% |
| 2016 FY | 705.6 Million CNY | 35.34% |
| 2015 Q1 | 122.86 Million CNY | 0.0% |
| 2015 Q3 | 145.45 Million CNY | 18.39% |
| 2015 Q4 | 145.31 Million CNY | -0.1% |
| 2015 FY | 521.37 Million CNY | 26.67% |
| 2015 Q2 | 122.86 Million CNY | 0.0% |
| 2014 FY | 411.59 Million CNY | 42.44% |
| 2013 FY | 288.95 Million CNY | 27.68% |
| 2012 FY | 226.31 Million CNY | 48.94% |
| 2011 FY | 151.94 Million CNY | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Shanghai Runda Medical Technology Co., Ltd. | 2.41 Billion CNY | -17.086% |
| Joinn Laboratories(China)Co.,Ltd. | 1.01 Billion CNY | -179.611% |
| WuXi AppTec Co., Ltd. | 16.27 Billion CNY | 82.603% |
| Thalys Medical Technology Group Inc. | 389.73 Million CNY | -626.609% |
| Guangzhou Kingmed Diagnostics Group Co., Ltd. | 3.11 Billion CNY | 9.092% |
| Chemclin Diagnostics Co., Ltd. | 335.61 Million CNY | -743.776% |